AcroMeta (SGX:43F) has entered into a side letter extending the exclusivity period for the proposed sale of its 70% stake in its unit Life Science Incubator, according to a Monday filing on the Singapore Exchange.
The new exclusivity period runs until Sept. 30.
The side letter updates certain terms and conditions of the previous non-binding term sheet signed on May 11. Key commercial terms remain unchanged.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。